AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maia, A. C. M.
Right arrow Articles by Stávale, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maia, A. C. M., Jr
Right arrow Articles by Stávale, J. N.

MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas

Antonio C. M. Maia, Jra,b, Suzana M. F. Malheirosb, Antonio J. da Rochaa, Carlos J. da Silvaa, Alberto A. Gabbaib, Fernando A. P. Ferrazc and João N. Stávaled

a Centro de Medicina Diagnóstica Fleury, Universidade Federal de São Paulo, Brazil
b Department of Neurology, Universidade Federal de São Paulo, Brazil
c Department of Neurosurgery, Universidade Federal de São Paulo, Brazil
d Department of Pathology, Universidade Federal de São Paulo, Brazil



View larger version (61K):

[in a new window]
 
FIG 1. Anaplastic astrocytoma. Axial enhanced T1–weighted image demonstrates a right frontal, nonenhancing lesion (A). rCBV map shows a markedly elevated rCBV of 3.6, which is consistent with biopsy-proved anaplastic astrocytoma (B). Immunohistochemical staining (400x) with monoclonal antibody against VEGF reveals strong cellular and endothelial positivity (C).



View larger version (57K):

[in a new window]
 
FIG 2. Diffuse astrocytoma. Axial enhanced T2-weighted image shows a left frontal nonenhancing lesion (A). rCBV map shows an obviously reduced rCBV of 0.72, which is consistent with biopsy-proved diffuse astrocytoma (WHO grade II). Immunohistochemical staining (400x) with the monoclonal antibody against VEGF is negative (C).



View larger version (58K):

[in a new window]
 
FIG 3. Diffuse astrocytoma. Axial enhanced T1-weighted image shows a left frontal nonenhancing lesion (A). rCBV map shows an elevated rCBV of 1.9 (B). Histologic section (400x) reveals a diffuse astrocytoma (WHO grade II), but VEGF staining shows strong cellular and endothelial positivity (C).



View larger version (60K):

[in a new window]
 
FIG 4. Anaplastic astrocytoma. Coronal enhanced T1-weighted image shows a heterogeneous left frontal lesion (A). rCBV map demonstrates a focal area with a high rCBV of 3.11. Histologic section (400X) of this focus is consistent with biopsy-proved anaplastic astrocytoma, and VEGF staining shows strong cellular and endothelial positivity (C).